Furthermore, among 11 OSA patients who submitted urine samples both before and after successful treatment with CPAP, treatment did not significantly affect the NGAL-to-creatinine ratio (Fig 5). This evidence concerns the gene LCN2 and obstructive sleep apnea syndrome.